Health ❯ Healthcare ❯ Patient Care

Oncology

Cancer Treatment Survival Rates Chemotherapy Treatment Outcomes Medication Access Advanced Melanoma Neurosurgery Recurrent Cancer Palliative Care Treatment Experiences Exercise Programs Medications Tumor Treatment Oncohematology Hormone Receptor Positive Breast Cancer Bladder Cancer Management Oncology Unit Contamination Child Health Delays in Treatment Aggressive Lymphoma Cancer Diagnosis Cancer Support Support Systems Support Networks Bone Marrow Transplant Muscle-Invasive Bladder Cancer Acute Lymphoblastic Leukemia Combination Therapy Surgical Procedures Relapsed/Refractory Multiple Myeloma Tumor Removal Advanced Cancer Metastatic Breast Cancer Urologic Oncology

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

Regulatory discussions are planned following independent confirmation of benefit.

FDA Clears Padcev Plus Keytruda Regimens as Perioperative Option for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Quitting After Cancer Diagnosis Linked to Higher Two-Year Survival, JNCCN Study Finds

FDA Approves J&J’s Inlexzo Bladder Drug-Delivery Device for BCG‑Unresponsive NMIBC

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors